Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity.
Bagratuni T, Patseas D, Mavrianou-Koutsoukou N, Liacos CI, Sklirou AD, Rousakis P, Gavriatopoulou M, Terpos E, Tsitsilonis OE, Trougakos IP, Kastritis E, Dimopoulos MA.
Bagratuni T, et al. Among authors: dimopoulos ma.
Cancers (Basel). 2020 Oct 5;12(10):2864. doi: 10.3390/cancers12102864.
Cancers (Basel). 2020.
PMID: 33028016
Free PMC article.